For informational purposes only — not investment advice

← Back to signals

ENTG

LONGINSIDER SELLCONGRESS BUY

ENTEGRIS INC

Research: Finviz ↗·Perplexity ↗

🗄 Viewing archived Q1 2026 data — frozen, no longer refreshed.

Funds
3
Score
3.57
vs SPY
+18.5%
Stock return (since Q-end)
+38.2%
SPY return (since Q-end)
+19.7%
Current price
$161.76
Days to cover (short int.)
2.8d↑+3.4%
as of 2026-07-31

News Summary

Positive

Entegris delivered strong operational execution with Q1-Q2 2026 earnings beats, accelerating revenue growth from 5% to 11% YoY, and raising Q3 guidance to imply mid-teens growth. The company is improving margins (gross margin hit highest since early 2022), reducing leverage below 3x by year-end, and benefits from visible demand across 20+ major semiconductor capacity expansions through 2027.

Red flags

  • New facilities in Taiwan (KSP) and Colorado (Rockrimmon) remain dilutive to P&L in 2026; KSP break-even not expected until year-end
  • Exit of US life sciences fluid management business and closure of Logan, Utah facility signal ongoing portfolio rationalization and past execution missteps
  • CFO transition completed only in mid-2026 with external hire; management stability recently tested following Bertrand Loy's retirement as Executive Chair

Funds Buying (3)

FundManagerShares Held∆ SharesPosition Value% of FundQoQStatus
Lone Pine CapitalSteve Mandel3.1M+61K$365M2.9%+2%Existing
Durable Capital PartnersHenry Ellenbogen972K+972K$114M1.2%NEW
Maverick CapitalLee Ainslie13K+13K$2M<0.1%NEW

Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.

Portfolio Context

Where ENTG ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.

Lone Pine Capital

position #18 of this fund's book

  1. 15BROOKFIELD CORP$454M
  2. 16TENET HEALTHCARE CORP$426M
  3. 17CAPITAL ONE FINL CORP$414M
  4. 18ENTEGRIS INC$365M
  5. 19US FOODS HLDG CORP$350M
  6. 20PERFORMANCE FOOD GROUP CO$341M
  7. 21MCKESSON CORP$339M
Durable Capital Partners

position #26 of this fund's book

  1. 23CLEAR SECURE INC$144M
  2. 24WARBY PARKER INC$135M
  3. 25SHOPIFY INC$115M
  4. 26ENTEGRIS INC$114M
  5. 27FABRINET$113M
  6. 28ACUITY INC$100M
  7. 29COLLIERS INTL GROUP INC$89M

Values are quarter-end position sizes. Shown only for funds where ENTG ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.

Signal History

QuarterDirectionFundsScorevs SPY
Q2 2026SHORT32.87-21.6%
Q1 2026LONG33.57+18.5%

Same issuer appearing in consecutive quarters — persistent institutional conviction. Returns are frozen at each archived quarter's last refresh.

Insider Activity

NameTitleTypeSharesPriceValueFiledSrc
Colella JosephSVP and General CounselSELL4K$164.48$0.64M2026-08-13
Rice Susan G.SVP, Global Human ResourcesSELL2K$149.52$0.31M2026-08-11
LEDERER JAMES PSELL4K$143.59$0.51M2026-06-03
Haris Clinton M.SVP & President, APS DivisionSELL7K$149.23$1.02M2026-05-27
Rice Susan G.SVP, Global Human ResourcesSELL7K$133.01$0.92M2026-05-15
Rice Susan G.SVP, Global Human ResourcesSELL13K$132.75$1.72M2026-05-15
Blachier OlivierSVP, Chief Strategy OfficerSELL2K$140.04$0.28M2026-05-14
Colella JosephSVP and General CounselSELL4K$140.25$0.55M2026-05-14
Colella JosephSVP and General CounselSELL2K$140.04$0.34M2026-05-14
Haris Clinton M.SVP & President, APS DivisionSELL6K$144.57$0.84M2026-05-14
LOY BERTRANDExecutive ChairSELL44K$144.41$6.37M2026-04-17
LOY BERTRANDExecutive ChairSELL17K$140.22$2.44M2026-04-14
Blachier OlivierSVP, Chief Strategy OfficerSELL275$115.57$0.03M2026-04-07
Colella JosephSVP and General CounselSELL2K$115.57$0.18M2026-04-07

Congressional Trading

MemberChamberStateTypeAmount RangeTransaction DateFiledSrc
April McClain DelaneyhouseMD06BUY$1,001 - $15,0002026-07-302026-08-03
April McClain DelaneyhouseMD06BUY$1,001 - $15,0002026-07-082026-08-03
April McClain DelaneyhouseMD06BUY$1,001 - $15,0002026-06-082026-07-07
April McClain DelaneyhouseMD06BUY$1,001 - $15,0002026-06-052026-07-07

Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures.